Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15769)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 6, 2015 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hematology
ISSN
2218-6204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Michiels JJ, Valster F, Wielenga J, Schelfout K, Raeve HD. European |
|---|---|
| URL: | https://www.wjgnet.com/2218-6204/full/v4/i3/16.htm |
| Number | Citing Articles |
| 1 |
Michiels Jan Jacques, Lam King H, Kate Fibo Ten, Kim Dong-Wook, Kim Myungshin, Shuvaev Vasily, Valster Francisca, Potters Vincent, Schroyens Wilfried, Andreescu Mihaela, Trifa Adrian, Pich Achille, De Raeve Hendrik. Novel European Asiatic Clinical, Laboratory, Molecular and Pathobiological (2015-2020 CLMP) criteria for JAK2V617F trilinear polycythemia vera (PV), JAK2exon12 PV and JAK2V617F, CALR and MPL515 thrombocythemias: From Dameshek to Constantinescu-Vainchenker, Kralovics and Michiels. International Journal of Bone Marrow Research 2020; 3(1): 001 doi: 10.29328/journal.ijbmr.1001011
|
| 2 |
Michiels Jan Jacques. European Clinical Laboratory, Molecular and Pathological (ECMP) criteria for prefibrotic JAK2V617F-Thrombocythemia and Polycythemia Vera versus MPL515- and CALR-Thrombocythemia and Myelofibrosis: From Dameshek to Michiels 1950-2018. International Journal of Bone Marrow Research 2019; 2(1): 001 doi: 10.29328/journal.ijbmr.1001002
|
| 3 |
Ewa Wiśniewska-Chudy, Łukasz Szylberg, Grzegorz Dworacki, Ewa Mizera-Nyczak, Andrzej Marszałek. pSTAT5 and ERK exhibit different expression in myeloproliferative neoplasms. Oncology Reports 2017; 37(4): 2295 doi: 10.3892/or.2017.5476
|
| 4 |
Jan Jacques Michiels, Hendrik De Raeve. Primary myelofibrosis is not primary anymore since the discovery of MPL515 and CALR mutations as driver causes of mono-linear megakaryocytic and dual megakaryocytic granulocytic myeloproliferation and secondary myelofibrosis. International Journal of Bone Marrow Research 2019; : 018 doi: 10.29328/journal.ijbmr.1001003
|
| 5 |
Jan Jacques Michiels, Yonggoo Kim, Myungshin Kim, Francisca Valster, Vincent Potters, Zwi Berneman, Alain Gadisseur, Wilfried Schroyens, Hendrik De Raeve. Bone marrow histology in CALR mutated thrombocythemia and myelofibrosis: results from two cross sectional studies in 70 newly diagnosed JAK2/MPL wild type thrombocythemia patients. International Journal of Bone Marrow Research 2019; 2(1): 064 doi: 10.29328/journal.ijbmr.1001006
|
| 6 |
Yonggoo Kim, Joonhong Park, Irene Jo, Gun Dong Lee, Jiyeon Kim, Ahlm Kwon, Hayoung Choi, Woori Jang, Hyojin Chae, Kyungja Han, Ki-Seong Eom, Byung-Sik Cho, Sung-Eun Lee, Jinyoung Yang, Seung-Hwan Shin, Hyunjung Kim, Yoon Ho Ko, Haeil Park, Jong Youl Jin, Seungok Lee, Dong Wook Jekarl, Seung-Ah Yahng, Myungshin Kim. Genetic–pathologic characterization of myeloproliferative neoplasms. Experimental & Molecular Medicine 2016; 48(7): e247 doi: 10.1038/emm.2016.55
|
| 7 |
Jan Jacques Michiels. Aspirin cures erythromelalgia and cerebrovascular disturbances in JAK2-thrombocythemia through platelet-cycloxygenase inhibition. World Journal of Hematology 2017; 6(3): 32-54 doi: 10.5315/wjh.v6.i3.32
|
| 8 |
Jan Jacques Michiels, Hendrik De Raeve, Francisca Valster, Vincent Potters, Yonggoo Kim, Myungshin Kim. Extension of 2016 World Health Organization (WHO) Classification into a New Set of Clinical, Laboratory, Molecular, and Pathological Criteria for the Diagnosis of Myeloproliferative Neoplasms: From Dameshek to Vainchenker, Green, and Kralovics. European Medical Journal 2017; : 72 doi: 10.33590/emj/10314481
|